Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nadim G. El Chakhtoura, Elie Saade, Alina Iovleva, Mohamad Yasmin, Brigid Wilson, Federico Perez & Robert A. Bonomo. (2018) Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward ‘molecularly targeted’ therapy. Expert Review of Anti-infective Therapy 16:2, pages 89-110.
Read now
Read now
Li-Fen Hu, Xi-Hai Xu, Hong-Ru Li, Li-Ping Gao, Xi Chen, Nian Sun, Yan-Yan Liu, Hua-Fa Ying & Jia-Bin Li. (2018) Surveillance of antimicrobial susceptibility patterns among Stenotrophomonas maltophilia isolated in China during the 10-year period of 2005–2014. Journal of Chemotherapy 30:1, pages 25-30.
Read now
Read now
Yun Cai, Nan Bai, Xu Liu, Beibei Liang, Jin Wang & Rui Wang. (2016) Tigecycline: Alone or in combination?. Infectious Diseases 48:7, pages 491-502.
Read now
Read now
Milena Bojkova, Rumyana Markovska, Temenuga Stoeva, Tanya Strateva, Dobrinka Ivanova, Valentina Popova & Ivan Mitov. (2015) Molecular epidemiology and antimicrobial susceptibility of Stenotrophomonas maltophilia in a Bulgarian university hospital over a 5-year period (2007–2012). Infectious Diseases 47:12, pages 932-934.
Read now
Read now
Articles from other publishers (18)
Ali Delgarm Shams-Abadi, Abdollah Mohammadian-Hafshejani, David L. Paterson, Rezvan Arash, Elham Asadi Farsani, Asieh Taji, Hamid Heidari & Milad Shahini Shams Abadi. (2023) The prevalence of colistin resistance in clinical Stenotrophomonas maltophilia isolates worldwide: a systematic review and meta-analysis. BMC Microbiology 23:1.
Crossref
Crossref
Maryam Banar, Azin Sattari-Maraji, Ghazal Bayatinejad, Elahe Ebrahimi, Leila Jabalameli, Reza Beigverdi, Mohammad Emaneini & Fereshteh Jabalameli. (2023) Global prevalence and antibiotic resistance in clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis. Frontiers in Medicine 10.
Crossref
Crossref
Masoud Dadashi, Bahareh Hajikhani, Nooshin Nazarinejad, Negin Noorisepehr, Shahrooz Yazdani, Ali Hashemi, Zahra Hashemizadeh, Mehdi Goudarzi & Sameni Fatemeh. (2023) Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: A systematic review and meta-analysis. Journal of Global Antimicrobial Resistance.
Crossref
Crossref
Xin Liao, Peiqiang Zhao, Liyuan Hou, Bob Adyari, Elvis Genbo Xu, Qiansheng Huang & Anyi Hu. (2023) Network analysis reveals significant joint effects of microplastics and tetracycline on the gut than the gill microbiome of marine medaka. Journal of Hazardous Materials 442, pages 129996.
Crossref
Crossref
Ana Lara-Oya. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity
656
661
.
Jean Gibb & Darren W. Wong. (2021) Antimicrobial Treatment Strategies for Stenotrophomonas maltophilia: A Focus on Novel Therapies. Antibiotics 10:10, pages 1226.
Crossref
Crossref
Shauna Jacobson Junco, Mary Catherine Bowman & R. Brigg Turner. (2021) Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy. International Journal of Antimicrobial Agents 58:2, pages 106367.
Crossref
Crossref
Lindsay M. Avery, Christina A. Sutherland & David P. Nicolau. (2019) In vitro investigation of synergy among fosfomycin and parenteral antimicrobials against carbapenemase-producing Enterobacteriaceae. Diagnostic Microbiology and Infectious Disease 95:2, pages 216-220.
Crossref
Crossref
Márió Gajdács & Edit Urbán. (2019) Epidemiological Trends and Resistance Associated with Stenotrophomonas maltophilia Bacteremia: A 10-Year Retrospective Cohort Study in a Tertiary-Care Hospital in Hungary. Diseases 7:2, pages 41.
Crossref
Crossref
Lindsay M. Avery & David P. Nicolau. (2018) Assessing the in vitro activity of ceftazidime/avibactam and aztreonam among carbapenemase-producing Enterobacteriaceae: Defining the zone of hope. International Journal of Antimicrobial Agents 52:5, pages 688-691.
Crossref
Crossref
Irina Negut, Valentina Grumezescu & Alexandru Grumezescu. (2018) Treatment Strategies for Infected Wounds. Molecules 23:9, pages 2392.
Crossref
Crossref
Hideki Araoka, Masaru Baba, Chikako Okada, Masahiro Abe, Muneyoshi Kimura & Akiko Yoneyama. (2017) Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia : in vitro effects and clinical efficacy in cancer patients. International Journal of Infectious Diseases 58, pages 18-21.
Crossref
Crossref
Li-Fen Hu, Guo-Sheng Chen, Qin-Xiang Kong, Li-Ping Gao, Xi Chen, Ying Ye & Jia-Bin Li. (2016) Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China. PLOS ONE 11:6, pages e0157693.
Crossref
Crossref
Étienne Ruppé, Paul-Louis Woerther & François Barbier. (2015) Mechanisms of antimicrobial resistance in Gram-negative bacilli. Annals of Intensive Care 5:1.
Crossref
Crossref
Sung-Yeon Cho, Dong-Gun Lee, Su-Mi Choi, Chulmin Park, Hye-Sun Chun, Yeon-Joon Park, Jae-Ki Choi, Hyo-Jin Lee, Sun Hee Park, Jung-Hyun Choi & Jin-Hong Yoo. (2015) Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations. BMC Infectious Diseases 15:1.
Crossref
Crossref
Ya-Ting Chang, Chun-Yu Lin, Yen-Hsu Chen & Po-Ren Hsueh. (2015) Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Frontiers in Microbiology 6.
Crossref
Crossref
J. W. Betts, L. M. Phee, N. Woodford & D. W. Wareham. (2014) Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia. European Journal of Clinical Microbiology & Infectious Diseases 33:9, pages 1565-1572.
Crossref
Crossref
Khalid Ahmed Al-Anazi & Asma M. Al-Jasser. (2014) Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation. Frontiers in Oncology 4.
Crossref
Crossref